Review
Recombinant Salmonella vectors in vaccine development
Affiliations
- PMID: 7958478
Item in Clipboard
Review
Recombinant Salmonella vectors in vaccine development
Dev Biol Stand.
1994.
Abstract
A diversity of means are available for the attenuation of Salmonella which can be used to immunize animals and humans orally to elicit mucosal, humoral and cellular immune responses. Avirulent Salmonellae can be genetically engineered to express foreign antigens and the recombinant avirulent Salmonellae are capable of stable, high-level expression of the foreign antigen in the orally immunized animal or human host. The resulting vaccines are safe, efficacious, and are easy and economical to use.
Similar articles
-
The use of live attenuated Salmonella for oral vaccination.Dev Biol Stand. 1994;82:35-42. Dev Biol Stand. 1994. PMID: 7958481 Review.
-
[Use of Salmonellas as a vector in the designing of recombinant vaccines].Vestn Ross Akad Med Nauk. 1997;(3):43-6. Vestn Ross Akad Med Nauk. 1997. PMID: 9181857 Review. Russian. No abstract available.
-
Salmonellae as oral vaccine carriers.Dev Biol Stand. 1995;84:245-53. Dev Biol Stand. 1995. PMID: 7796961 Review. No abstract available.
-
Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.Parasite Immunol. 1987 Mar;9(2):151-60. doi: 10.1111/j.1365-3024.1987.tb00496.x. Parasite Immunol. 1987. PMID: 3106921 Review.
-
The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines.Behring Inst Mitt. 1994 Dec;(95):49-56. Behring Inst Mitt. 1994. PMID: 7755509 Review. No abstract available.
Cited by
-
A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.Pathog Dis. 2017 Nov 30;75(8):ftx102. doi: 10.1093/femspd/ftx102. Pathog Dis. 2017. PMID: 28911037 Free PMC article.
-
Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses.Infect Immun. 1999 Mar;67(3):1093-9. doi: 10.1128/IAI.67.3.1093-1099.1999. Infect Immun. 1999. PMID: 10024548 Free PMC article.
-
Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants.Infect Immun. 1997 Dec;65(12):5381-7. doi: 10.1128/iai.65.12.5381-5387.1997. Infect Immun. 1997. PMID: 9393846 Free PMC article.
-
Overview of vaccines.Mol Biotechnol. 1997 Oct;8(2):123-34. doi: 10.1007/BF02752256. Mol Biotechnol. 1997. PMID: 9406182 Review.
-
The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.Infect Immun. 1999 Jul;67(7):3674-9. doi: 10.1128/IAI.67.7.3674-3679.1999. Infect Immun. 1999. PMID: 10377159 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical